Products

Solutions

21 CFR 211.166 - Stability Testing

Overview:

21 CFR 211.166 sets stability testing requirements for drug products to determine appropriate storage conditions and expiration dates. 

The regulation outlines testing programs, including sample sizes, test intervals, and methods, to ensure drug product stability

It serves pharmaceutical manufacturers and processors to establish valid expiration dates and ensure the safety and efficacy of drug products throughout their shelf life.

(a) 

There shall be a written testing program designed to assess the stability characteristics of drug products. The results of such stability testing shall be used in determining appropriate storage conditions and expiration dates. The written program shall be followed and shall include:

(1) Sample size and test intervals based on statistical criteria for each attribute examined to assure valid estimates of stability;

(2) Storage conditions for samples retained for testing;

(3) Reliable, meaningful, and specific test methods;

(4) Testing of the drug product in the same container-closure system as that in which the drug product is marketed;

(5) Testing of drug products for reconstitution at the time of dispensing (as directed in the labeling) as well as after they are reconstituted.

(b) 

An adequate number of batches of each drug product shall be tested to determine an appropriate expiration date and a record of such data shall be maintained. Accelerated studies, combined with basic stability information on the components, drug products, and container-closure system, may be used to support tentative expiration dates provided full shelf life studies are not available and are being conducted. Where data from accelerated studies are used to project a tentative expiration date that is beyond a date supported by actual shelf life studies, there must be stability studies conducted, including drug product testing at appropriate intervals, until the tentative expiration date is verified or the appropriate expiration date determined.

(c) 

For homeopathic drug products, the requirements of this section are as follows:

(1) There shall be a written assessment of stability based at least on testing or examination of the drug product for compatibility of the ingredients, and based on marketing experience with the drug product to indicate that there is no degradation of the product for the normal or expected period of use.

(2) Evaluation of stability shall be based on the same container-closure system in which the drug product is being marketed.

(d) 

Allergenic extracts that are labeled “No U.S. Standard of Potency” are exempt from the requirements of this section.

Compliance AI Agents

for consumer products

Signify helps regulatory and product compliance teams in CPG and durables manufacturing launch products faster by automating global compliance.

Signify is the leading compliance system for consumer products—leveraging AI agents to automate gap analysis, streamline conformity checks, and accelerate safe, high-quality product launches.

Company

About Us

Terms of Service

Privacy Policy

DPA

Resources

Blog

Guides

Why Now

21 CFR

Use Cases

Supplier Check

Labeling

Internal Audits

Quality & Safety

Import & Export

Signify SOC2 Type 2 Compliant

© 2025 Signify Technologies, Corp.

Compliance AI Agents

for consumer products

Signify helps regulatory and product compliance teams in CPG and durables manufacturing launch products faster by automating global compliance.

Signify is the leading compliance system for consumer products—leveraging AI agents to automate gap analysis, streamline conformity checks, and accelerate safe, high-quality product launches.

Company

About Us

Terms of Service

Privacy Policy

DPA

Resources

Blog

Guides

Why Now

21 CFR

Use Cases

Supplier Check

Labeling

Internal Audits

Quality & Safety

Import & Export

Signify SOC2 Type 2 Compliant

© 2025 Signify Technologies, Corp.

Compliance AI Agents

for consumer products

Signify helps regulatory and product compliance teams in CPG and durables manufacturing launch products faster by automating global compliance.

Signify is the leading compliance system for consumer products—leveraging AI agents to automate gap analysis, streamline conformity checks, and accelerate safe, high-quality product launches.

Signify SOC2 Type 2 Compliant

© 2025 Signify Technologies, Corp.

Use Cases

Supplier Check

Labeling

Internal Audits

Quality & Safety

Import & Export

Resources

Blog

Guides

Why Now

21 CFR

Company

About Us

Terms of Service

Privacy Policy

DPA

Compliance AI Agents

for consumer products

Signify helps regulatory and product compliance teams in CPG and durables manufacturing launch products faster by automating global compliance.

Signify is the leading compliance system for consumer products—leveraging AI agents to automate gap analysis, streamline conformity checks, and accelerate safe, high-quality product launches.

Use Cases

Supplier Check

Labeling

Internal Audits

Quality & Safety

Import & Export

Resources

Blog

Guides

Why Now

21 CFR

Company

About Us

Terms of Service

Privacy Policy

DPA

Signify SOC2 Type 2 Compliant

© 2025 Signify Technologies, Corp.